Clene (CLNN) vs MEDIFAST INC (MED)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
MEDIFAST INC (MED) has outperformed Clene (CLNN) over the past year, losing 18.5% versus a loss of 58.8%. Over five years, MED leads with a -94.0% price change compared with -96.9% for CLNN. MEDIFAST INC is the larger company by market cap ($127.8 million vs $55.2 million), about 2.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLNN | MED |
|---|---|---|
| Share price | $3.88 | $11.43 |
| Market cap | $55.15M | $127.80M |
| 1-day change | -1.02% | -0.09% |
| YTD return | -33.90% | +7.02% |
| 1-year return | -58.81% | -18.47% |
| 5-year return | -96.86% | -94.01% |
| EPS (TTM) | $-3.52 | $-2.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.50 | $14.06 |
| 52-week low | $3.25 | $9.22 |
| Distance from 52-week high | -71.26% | -18.71% |
| Analyst consensus | none | none |
| Avg. price target upside | +729.90% | +4.99% |
| Average volume | 100.21K | 148.78K |
| Shares outstanding | 14.21M | 11.18M |
| Employees | 76 | 380 |
| Sector | Consumer Defensive | Consumer Staples |
| Industry | Packaged Foods | Packaged Foods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MEDIFAST INC is about 2.3 times larger than Clene by market value ($127.80M vs $55.15M).
- MED has outperformed CLNN by 40.3 percentage points over the past year.
- The two companies sit in different sectors: Clene in Consumer Defensive and MEDIFAST INC in Consumer Staples.
About Clene
CLNN stock →Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.
Consumer Defensive · Packaged Foods · 76 employees
About MEDIFAST INC
MED stock →Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements.
Consumer Staples · Packaged Foods · 380 employees
CLNN vs MED FAQ
Which is bigger, Clene or MEDIFAST INC?
MEDIFAST INC (MED) is larger, with a market capitalization of $127.80M compared with $55.15M for Clene (CLNN).
Which stock has performed better over the past year, CLNN or MED?
MED returned -18.47% over the past 12 months, compared with -58.81% for CLNN (price return, excluding dividends). Past performance does not predict future results.
Are Clene and MEDIFAST INC in the same industry?
Yes. Both are classified in the Packaged Foods industry within the Consumer Defensive sector.